Clinical Trial Update: A Comparison of White-light and Daylight Topical Methyl 5-aminolaevulinic Acid Photodynamic Therapy for Actinic Keratoses [NA]

View source ↗

Summary

A completed clinical trial comparing white-light versus daylight topical methyl 5-aminolevulinic acid photodynamic therapy for actinic keratosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Methyl aminolevulinate (methyl aminolevulinate)

Snippet

Sponsor: St Vincent's University Hospital, Ireland | Conditions: Actinic Keratoses | NA | Status: COMPLETED